Literature DB >> 8684159

Health services: an Italian market.

A del Favero1, G Barro, G Vicari, F Rovelli, G Tognoni, L Bozzini, N Martini, L Pagliaro, G Remuzzi.   

Abstract

One of the glories of Italy is its capacity to surprise. In out-of-the-way places extraordinary things are suddenly encountered; and this is hardly less true of science than of architecture or music or painting. Italian medicine can boast excellence in many quiet spots. Yet Italy's record in medical science and practice is perceived to be below par, and one reason may be a lack of central coordination--forgivable in a country that had fifty governments in half a century. The latest administration offers a rare chance of political stability and the prospect of reforms. In this profile of Italian medicine The Lancet's guide was Dr Giuseppe Remuzzi, whose central coordination was exemplary.

Mesh:

Substances:

Year:  1996        PMID: 8684159     DOI: 10.1016/s0140-6736(96)05024-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  2 in total

1.  Impact of a DRG-based hospital financing system on quality and outcomes of care in Italy.

Authors:  D Z Louis; E J Yuen; M Braga; A Cicchetti; C Rabinowitz; C Laine; J S Gonnella
Journal:  Health Serv Res       Date:  1999-04       Impact factor: 3.402

2.  Treatment of chronic heart failure with beta adrenergic blockade beyond controlled clinical trials: the BRING-UP experience.

Authors:  A P Maggioni; G Sinagra; C Opasich; E Geraci; M Gorini; E Gronda; D Lucci; G Tognoni; E Balli; L Tavazzi
Journal:  Heart       Date:  2003-03       Impact factor: 5.994

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.